|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-8-11
|
|
pubmed:abstractText |
Interleukin 33 (IL-33) is a new member of the IL-1 family of cytokines which signals via its receptor, ST2 (IL-33R), and has an important role in Th2 and mast cell responses. This study shows that IL-33 orchestrates neutrophil migration in arthritis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chemotactic Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/IL33 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Il1rl1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-33, mouse
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
pubmed-author:AlmeidaSergio C LSC,
pubmed-author:Alves-FilhoJose CJC,
pubmed-author:CunhaFernando QFQ,
pubmed-author:CunhaThiago MTM,
pubmed-author:FerreiraSergio HSH,
pubmed-author:FukadaSandra YSY,
pubmed-author:GuerreroAna T GAT,
pubmed-author:LiewFoo YFY,
pubmed-author:Louzada-JuniorPauloP,
pubmed-author:Mattos-GuimaraesRafaela BRB,
pubmed-author:McInnesIain BIB,
pubmed-author:OliveiraFabíola RFR,
pubmed-author:SilvaJoão SJS,
pubmed-author:SoutoFabrício OFO,
pubmed-author:TeixeiraMauro MMM,
pubmed-author:VerriWaldiceu AWAJr,
pubmed-author:VieiraSilvio MSM,
pubmed-author:XuDamoD
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1697-703
|
|
pubmed:meshHeading |
pubmed-meshheading:20472598-Animals,
pubmed-meshheading:20472598-Antirheumatic Agents,
pubmed-meshheading:20472598-Arthritis, Experimental,
pubmed-meshheading:20472598-Arthritis, Rheumatoid,
pubmed-meshheading:20472598-Chemotactic Factors,
pubmed-meshheading:20472598-Chemotaxis, Leukocyte,
pubmed-meshheading:20472598-Cytokines,
pubmed-meshheading:20472598-Gene Expression Regulation,
pubmed-meshheading:20472598-Humans,
pubmed-meshheading:20472598-Interleukins,
pubmed-meshheading:20472598-Macrophage Activation,
pubmed-meshheading:20472598-Mice,
pubmed-meshheading:20472598-Mice, Inbred BALB C,
pubmed-meshheading:20472598-Mice, Inbred C57BL,
pubmed-meshheading:20472598-Neutrophil Infiltration,
pubmed-meshheading:20472598-RNA, Messenger,
pubmed-meshheading:20472598-Receptors, Interleukin,
pubmed-meshheading:20472598-Synovial Membrane,
pubmed-meshheading:20472598-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy.
|
|
pubmed:affiliation |
Department of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil. waverri@uel.br
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
